Latest Editor Advisory
We Recommended Taking Profits of as Much as $4,707,00 on CRSP on January 2, 2019
Our Erlanger Signals working!
World Opportunity Investor 2020 Market Outlook
Our 2020 outlook includes bullish and bearish case for the markets; valuations, price targets; technicals and price analysis; and the psychology, sentiment and focus of the markets; summary and conclusion.
Our 2020 Economic Outlook
Take your profits on our recommended gold 3X ETF position.
This Overvalued Market Just Broke Out to New Highs!
With a whopping $3.4 Trillion still sitting on the sidelines in cash are we headed for a spectacular new leg up, or towards a ‘black swan’ nose dive?
Gene-Editing Company Focuses on Developing Gene-Based Medicines for Serious Diseases.
Thanks to accelerating medical technologies taking place in science and medical laboratories around the world, we wouldn’t be surprised to see this stock begin an amazing run!
We're still very wary of a major market correction driven by the continuing threat from the Coronavirus (COVID-19)
However, we can’t ignore the clear buy signal!
Biogen (BIIB) Soars, Catches Us by Surprise
Why we are being so conservative with our recommendations right now.
Take Your Profits on Biogen!
The price of the option didn’t decline enough yesterday. We are taking our profits TODAY!
We're Not Wrong!
The danger from the Wuhan Coronavirus is growing and the world is facing a nightmarish pandemic that will infect millions and possibly kill hundreds of thousands in China and around the world.
A Full Fledge Chinese Crackdown on Hong Kong Endangers China's Publicly Listed Stock Valuations!
We’re increasingly concerned that our favorite Chinese stocks could suffer a sudden 10%, even 15% pullback if Beijing decides to send in the tens of thousands of its People's Liberation Army to quell the increasingly violent protests taking place in Hong Kong.
2-Year Yield and Fed Funds Finally in Balance Setting Up A Goldilocks Nirvanna
Special Update from one of my favorite technical analysts Tom McClellan give cause for a goldilocks U.S. market when most analysts are very worried ...
Latest Special Reports
Over 100 Biotechnology Companies Focused on CAR-T Cancer Treatments and Technologies
List of companies that are involved in the development and research of CAR-T health solutions
UPDATE - In the Age of Precision Genomics, Frelii Could be the Investment of a Lifetime
UPDATE ALERT - MAJOR CHANGE MADE TO FRELII POSITION - INCLUDED IN ISSUE #37
The Best Time to Invest, Buy Stocks/Markets
In other words – BUY LOW, when the market is undervalued. Here’s how to pin down when market has bottomed.
Live to 150 and Grow Filthy Rich along the Way
THe Holy Grail of Aging
Three Companies With Pioneering Gene-Editing Treatments
Companies on the Crusp of Stunning Medical Breakthroughs